MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank80
3Y CAGR+18.8%
5Y CAGR+148.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+18.8%/yr
Annual compound
5Y CAGR
+148.5%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
94.8x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$5.02M+6.5%
2024$4.71M-27.5%
2023$6.50M+117.2%
2022$2.99M+288.5%
2021$770115.00+1353.5%
2020$52982.00-